Ver registro no DEDALUS
Exportar registro bibliográfico

Metrics


Metrics:

Is Silver Nitrate Pleurodesis for Patients with Malignant Pleural Effusion Feasible and Safe When Performed in an Outpatient Setting? (2011)

  • Authors:
  • USP affiliated authors: FERNANDES, PAULO MANUEL PEGO - FM ; TEIXEIRA, LISETE RIBEIRO - FM ; SUSO, FRANCISCO VARGAS - FM ; JATENE, FABIO BISCEGLI - FM
  • USP Schools: FM; FM; FM; FM
  • DOI: 10.1245/s10434-010-1447-8
  • Subjects: NITRATOS; PRATA; DERRAME PLEURAL MALIGNO; PLEURODESE
  • Language: Inglês
  • Imprenta:
  • Source:
  • Acesso online ao documento

    Online accessDOI or search this record in
    Informações sobre o DOI: 10.1245/s10434-010-1447-8 (Fonte: oaDOI API)
    • Este periódico é de assinatura
    • Este artigo NÃO é de acesso aberto
    • Cor do Acesso Aberto: closed
    Informações sobre o Citescore
  • Título: Annals of Surgical Oncology

    ISSN: 1068-9265

    Citescore - 2017: 3.7

    SJR - 2017: 1.986

    SNIP - 2017: 1.467


  • Exemplares físicos disponíveis nas Bibliotecas da USP
    BibliotecaCód. de barrasNúm. de chamada
    FM2184166-10BCSEP 106 2011
    How to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      TERRA, Ricardo Mingarini; KIM, So Yeon; PEGO-FERNANDES, Paulo Manuel; et al. Is Silver Nitrate Pleurodesis for Patients with Malignant Pleural Effusion Feasible and Safe When Performed in an Outpatient Setting? Annals of Surgical Oncology, New York, v. 18, n. 9, p. 1145-115, 2011. Disponível em: < DOI: 10.1245/s10434-010-1447-8 > DOI: 10.1245/s10434-010-1447-8.
    • APA

      Terra, R. M., Kim, S. Y., Pego-Fernandes, P. M., Teixeira, L. R., Vargas, F. S., & Jatene, F. B. (2011). Is Silver Nitrate Pleurodesis for Patients with Malignant Pleural Effusion Feasible and Safe When Performed in an Outpatient Setting? Annals of Surgical Oncology, 18( 9), 1145-115. doi:10.1245/s10434-010-1447-8
    • NLM

      Terra RM, Kim SY, Pego-Fernandes PM, Teixeira LR, Vargas FS, Jatene FB. Is Silver Nitrate Pleurodesis for Patients with Malignant Pleural Effusion Feasible and Safe When Performed in an Outpatient Setting? [Internet]. Annals of Surgical Oncology. 2011 ; 18( 9): 1145-115.Available from: DOI: 10.1245/s10434-010-1447-8
    • Vancouver

      Terra RM, Kim SY, Pego-Fernandes PM, Teixeira LR, Vargas FS, Jatene FB. Is Silver Nitrate Pleurodesis for Patients with Malignant Pleural Effusion Feasible and Safe When Performed in an Outpatient Setting? [Internet]. Annals of Surgical Oncology. 2011 ; 18( 9): 1145-115.Available from: DOI: 10.1245/s10434-010-1447-8

    Referências citadas na obra
    Lynch TJ Jr. Management of malignant pleural effusions. Chest. 1993;103:385S–9S.
    Neto JD, de Oliveira SF, Vianna SP, Terra RM. Efficacy and safety of iodopovidone pleurodesis in malignant pleural effusions. Respirology. 2010;15:115–8.
    de Campos JR, Vargas FS, de Campos Werebe E, Cardoso P, Teixeira LR, Jatene FB, et al. Thoracoscopy talc poudrage: a 15-year experience. Chest. 2001;119:801–6.
    Walker-Renard PB, Vaughan LM, Sahn SA. Chemical pleurodesis for malignant pleural effusions. Ann Intern Med. 1994;120:56–64.
    Shaw P, Agarwal R. Pleurodesis for malignant pleural effusions (Cochrane Review). In: The Cochrane Library. Issue 4, 2004. Oxford: Updated Software.
    Kennedy L, Rusch VW, Strange C, Ginsberg RJ, Sahn SA. Pleurodesis using talc slurry. Chest. 1994;106:342–6.
    Werebe EC, Pazetti R, Milanez de Campos JR, Fernandez PP, Capelozzi VL, Jatene FB, Vargas FS. Systemic distribution of talc after intrapleural administration in rats. Chest. 1999;115:190–93.
    de Campos JR, Werebe EC, Vargas FS, Jatene FB, Light RW. Respiratory failure due to insufflated talc. Lancet. 1997;349:251.
    Rehse DH, Aye RW, Florence MG. Respiratory failure after talc pleurodesis. Am J Surg. 1999;177:437–40.
    Janssen JP, Collier G, Astoul P, Tassi GF, Noppen M, Rodriguez-Panadero F, et al. Safety of pleurodesis with talc poudrage in malignant pleural effusion: a prospective cohort study. Lancet. 2007;369:1535–9.
    Genofre EH, Vargas FS, Acencio MM, Antonangelo L, Teixeira LR, Marchi E. Talc pleurodesis: evidence of systemic inflammatory response to small size talc particles. Respir Med. 2009;103:91–7.
    Maskell NA, Lee YC, Gleeson FV, Hedley EL, Pengelly G, Davies RJ. Randomized trials describing lung inflammation after pleurodesis with talc of varying particle size. Am J Respir Crit Care Med. 2004;170:377–82.
    Ferrer J, Montes JF, Villarino MA, Light RW, Garcia-Valero J. Influence of particle size on extrapleural talc dissemination after talc slurry pleurodesis. Chest. 2002;122:1018–27.
    Paschoalini M da S, Vargas FS, Marchi E, Pereira JR, Jatene FB, Antonangelo L, et al. Prospective randomized trial of silver nitrate vs talc slurry in pleurodesis for symptomatic malignant pleural effusions. Chest. 2005;128:684–9.
    Vargas FS, Teixeira LR, Vaz MA, Carmo AO, Marchi E, Cury PM, et al. Silver nitrate is superior to talc slurry in producing pleurodesis in rabbits. Chest. 2000;118:808–13.
    Saffran L, Ost DE, Fein AM, Schiff MJ. Outpatient pleurodesis of malignant pleural effusions using a small-bore pigtail catheter. Chest. 2000;118:417–21.
    Spiegler PA, Hurewitz AN, Groth ML. Rapid pleurodesis for malignant pleural effusions. Chest. 2003;123:1895–8.
    Cancer Therapy Evaluation Program, Common Terminology Criteria for Adverse Events, Version 3.0, DCTD, NCI, NIH, DHHS, March 31, 2003 ( http://ctep.cancer.gov ), Publish Date: August 9, 2006.
    The WHOQoL Group. The development of the World Health Organization quality of life assessment instrument (the WHOQoL). In: Orley J, Kuyken W, eds. Quality of Life Assessment: International Perspectives. Heidelberg: Springer Verlag, 1994.
    Fleck MPA, Leal OF, Louzada S, Xavier M, Chachamovich E, Vieira G, et al. Desenvolvimento da versão em português do instrumento de avaliação de qualidade de vida da OMS (WHOQoL-100) 1999. Rev Bras Psiquiatr. 1999;21:19–28.
    Wied U, Andersen K, Schultz A, Rasmussen E, Watt-Boolsen S. Silver nitrate pleurodesis in spontaneous pneumothorax. Scand J Thorac Cardiovasc Surg. 1981;15:305–7.
    Wied U, Halkier E, Hoeier-Madsen K, Plucnar B, Rasmussen E, Sparup J. Tetracycline versus silver nitrate pleurodesis in spontaneous pneumothorax. J Thorac Cardiovasc Surg. 1983;86:591–3.
    Vargas FS, Teixeira LR, Silva LM, Carmo AO, Light RW. Comparison of silver nitrate and tetracycline as pleural sclerosing agents in rabbits. Chest. 1995;108:1080–3.
    Vargas FS, Antonangelo L, Capelozzi V, Vaz MA, Genofre EH, Marchi E, et al. Lung damage in experimental pleurodesis induced by silver nitrate or talc: 1-year follow-up. Chest. 2002;122:2122–6.
    Terra RM, Teixeira LR, Bibas BJ, Pego-Fernandes PM, Vargas FS, Jatene FB. Effectiveness and safety of outpatient pleurodesis in patients with recurrent malignant pleural effusion and low performance status. Clinics. 2011 [Epub ahead of print].
    Tremblay A, Michaud G. Single-center experience with 250 tunnelled pleural catheter insertions for malignant pleural effusion. Chest. 2006;129:362–8.
    Warren WH, Kim AW, Liptay MJ. Identification of clinical factors predicting Pleurx catheter removal in patients treated for malignant pleural effusion. Eur J Cardiothorac Surg. 2008;33:89–94.